- Normalized FFO for the second quarter grew 10.7% year-over-year to $44.1 million. Over the same time period, normalized FFO per share increased 5.0%.
- For the trailing twelve months ended June 30, 2016, same store revenue grew 4.0%, operating expenses increased 3.4%, and same store NOI grew 4.3%.
- Same store revenue per average occupied square foot increased 3.3% over the prior year.
- Average same store occupancy increased to 89.9% from 89.3% a year ago.
- Leasing activity totaled 418,000 square feet related to 137 leases:
- 260,000 square feet of renewals
- 158,000 square feet of new and expansion leases
- Four predictive growth measures in the same store multi-tenant portfolio:
- Contractual rent increases occurring in the quarter averaged 2.9%
- Cash leasing spreads were 6.3% on 228,000 square feet renewed: 0% of square feet (<0% spread), 12% (0-3%), 41% (3-4%) and 47% (>4%)
- Tenant retention was 81.2%
- The average yield on renewed leases increased 90 basis points
- In April 2016, the Company acquired a 100% leased, 46,600 square foot medical office building in Seattle, Washington for a purchase price of $21.6 million. The property is located on UW Medicine's Valley Medical Center campus.
- In May 2016, the Company acquired an 80% leased, 63,000 square foot medical office building in Los Angeles, California for a purchase price of $20.0 million. The property is located on HCA's West Hills Hospital and Medical Center campus.
- The Company is working on the acquisition of two MOBs for a combined purchase price of $98 million and expects to close in October 2016. These properties total 191,000 square feet, are 100% leased, and are on hospital campuses in Seattle and Washington, D.C.
- On July 5, 2016, the Company completed the sale of 9.2 million shares of common stock for net proceeds of approximately $304.6 million to fund investment activity.
- During the second quarter, the Company sold 2.4 million shares through the at-the-market (ATM) program, generating net proceeds of $74.9 million.
- In July 2016, the Company renewed its $700 million unsecured credit facility. The new credit facility includes 14 banks and matures in July 2020 with an option to extend the facility for an additional year.
- In July 2016, S&P Global Ratings upgraded the Company's senior unsecured debt rating to BBB.
- A dividend of $0.30 per common share was declared, which is equal to 71.4% of normalized FFO per share.
Additional information regarding the Company, including this quarter's operations, can be found at www.healthcarerealty.com. Please contact the Company at 615.269.8175 to request a printed copy of this information.In addition to the historical information contained within, the matters discussed in this press release may contain forward-looking statements that involve risks and uncertainties. These risks are discussed in filings with the Securities and Exchange Commission by Healthcare Realty Trust, including its Annual Report on Form 10-K for the year ended December 31, 2015 under the heading "Risk Factors," and as updated in its Quarterly Reports on Form 10-Q filed thereafter. Forward-looking statements represent the Company's judgment as of the date of this release. The Company disclaims any obligation to update forward-looking statements. HEALTHCARE REALTY TRUST INCORPORATEDCondensed Consolidated Balance Sheets (1)(amounts in thousands, except per share data)
|Real estate properties:||6/30/2016||12/31/2015|
|Buildings, improvements and lease intangibles||3,235,744||3,135,893|
|Construction in progress||35,174||19,024|
|Land held for development||17,438||17,452|
|Total real estate properties||3,506,774||3,380,908|
|Less accumulated depreciation and amortization||(819,744||)||(761,926||)|
|Total real estate properties, net||2,687,030||2,618,982|
|Cash and cash equivalents||9,026||4,102|
|Assets held for sale and discontinued operations, net||710||724|
|Other assets, net||185,298||186,416|
|LIABILITIES AND STOCKHOLDERS' EQUITY|
|Notes and bonds payable||$||1,414,739||$||1,424,992|
|Accounts payable and accrued liabilities||70,408||75,489|
|Liabilities of discontinued operations||17||33|
|Commitments and contingencies|
|Preferred stock, $.01 par value; 50,000 shares authorized; none issued and outstanding||—||—|
|Common stock, $.01 par value; 150,000 shares authorized; 106,662 and 101,517 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively||1,067||1,015|
|Additional paid-in capital||2,609,880||2,461,376|
|Accumulated other comprehensive income||(1,485||)||(1,569||)|
|Cumulative net income attributable to common stockholders||930,985||909,685|
|Total stockholders' equity||1,350,448||1,242,747|
|Total liabilities and stockholders' equity||$||2,882,064||$||2,810,224|
HEALTHCARE REALTY TRUST INCORPORATEDCondensed Consolidated Statements of Income (1)(amounts in thousands, except per share data)(Unaudited)
|Three Months Ended June 30,||Six Months Ended June 30,|
|General and administrative||8,129||6,713||18,375||13,451|
|Bad debts, net of recoveries||78||27||39||(181||)|
|Other Income (Expense)|
|Gain on sales of real estate properties||1||41,549||1||41,549|
|Loss on extinguishment of debt||—||(27,998||)||—||(27,998||)|
|Impairment of real estate assets||—||—||—||(3,328||)|
|Impairment of internally-developed software||—||(654||)||—||(654||)|
|Interest and other income, net||93||147||179||239|
|Income From Continuing Operations||12,157||17,586||21,320||22,635|
|Income (loss) from discontinued operations||(19||)||330||(27||)||663|
|Gain on sales of real estate properties||7||—||7||—|
|Income (Loss) From Discontinued Operations||(12||)||330||(20||)||663|
|Basic Earnings Per Common Share:|
|Income from continuing operations||$||0.12||$||0.18||$||0.21||$||0.23|
|Diluted Earnings Per Common Share:|
|Income from continuing operations||$||0.12||$||0.18||$||0.21||$||0.23|
|Weighted Average Common Shares Outstanding—Basic||103,988||99,273||102,710||98,819|
|Weighted Average Common Shares Outstanding—Diluted||104,770||99,945||103,471||99,554|
HEALTHCARE REALTY TRUST INCORPORATEDReconciliation of FFO and Normalized FFO (1)(amounts in thousands, except per share data)(Unaudited)Non-GAAP MeasuresManagement considers funds from operations ("FFO"), FFO per share, normalized FFO, and normalized FFO per share to be useful non-GAAP measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure historical or future financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors. The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income (determined in accordance with GAAP), as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs.
|Gain on sales of real estate properties||(8||)||(41,549||)|
|Real estate depreciation and amortization||31,716||29,388|
|Funds From Operations||$||43,853||$||5,755|
|Loss on extinguishment of debt||—||27,998|
|Impairment of internally-developed software||—||654|
|Normalized Funds From Operations||$||44,089||$||39,834|
|Funds from Operations per Common Share—Diluted||$||0.42||$||0.06|
|Normalized Funds From Operations Per Common Share—Diluted||$||0.42||$||0.40|
|FFO Weighted Average Common Shares Outstanding||104,770||99,945|
Management believes FFO, FFO per share, Normalized FFO, and Normalized FFO per share provide an understanding of the operating performance of the Company's properties without giving effect to certain significant non-cash items, including depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, gains or losses from sales of real estate, and other normalizing items that are unusual and infrequent, FFO, FFO per share, Normalized FFO, and Normalized FFO per share can facilitate comparisons of operating performance between periods. The Company reports these measures because they have been observed by management to be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs and because these measures are consistently reported, discussed, and compared by research analysts in their notes and publications about REITs. However, these measures do not represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. FFO, FFO per share, Normalized FFO, and Normalized FFO per share should not be considered as an alternative to net income attributable to common stockholders as an indicator of the Company's operating performance or as an alternative to cash flow from operating activities as a measure of liquidity.(2) During the third quarter of 2015, the Company began including an add-back for leasing commission amortization in order to provide a better basis for comparing its results of operations with those of others in the industry, consistent with the NAREIT definition of FFO. For the three ended June 30, 2015, FFO per diluted common share was previously reported as $0.05.
Carla BacaDirector of Corporate CommunicationsP: 615.269.8175